November 19, 2024
No two people look at a painting or watch a performance the same way. One might pick up color, brushstrokes, the resonance of a voice. Another might see a hidden figure, the shape of a smile, or the lightness in the footsteps as an actor crosses the stage.
November 18, 2024
In 2015, Orlando Rosales was washing his truck. Suddenly, a man approached him with a gun. Minutes later, a bullet shattered Rosales' right femur. With the help of a UTHealth Houston orthopedic surgeon, Rosales was able to walk again and the recovered bullet led to the identity of the man who shot him.
November 18, 2024
UTHealth Houston and its community members received three prestigious 2024 National Philanthropy Day Awards from the Association of Fundraising Professionals (AFP) Greater Houston Chapter during its annual luncheon held Wednesday, Nov. 13.
November 1, 2024
Medicare-certified home health agencies, which are key to allowing older adults to age in place, are increasingly going through ownership changes, raising concerns about health care spending, workforce, and quality of care, according to a study by UTHealth Houston.
October 21, 2024
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London.
October 16, 2024
Nurses from UTHealth Houston’s Behavioral Sciences Campus, UT Physicians, and Cizik School of Nursing at UTHealth Houston have been selected by The Good Samaritan Foundation of Texas for its 20th annual Excellence in Nursing Awards.
October 10, 2024
Ashley Hallock, 35, describes the day she joined a clinical trial studying stem cells for bipolar disorder as the most important day of her life.
“For me, it was a godsend,” she said.
October 9, 2024
Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.
October 8, 2024
An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight Texas primary care community health centers that treat under- and uninsured patients.
October 7, 2024
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
The recipient, 79-year-old Terrie Frankel, received the infusion last week.